O. Schmitz

6.3k total citations · 1 hit paper
113 papers, 4.9k citations indexed

About

O. Schmitz is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, O. Schmitz has authored 113 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Endocrinology, Diabetes and Metabolism, 48 papers in Physiology and 40 papers in Molecular Biology. Recurrent topics in O. Schmitz's work include Metabolism, Diabetes, and Cancer (33 papers), Diet and metabolism studies (32 papers) and Diabetes Management and Research (26 papers). O. Schmitz is often cited by papers focused on Metabolism, Diabetes, and Cancer (33 papers), Diet and metabolism studies (32 papers) and Diabetes Management and Research (26 papers). O. Schmitz collaborates with scholars based in Denmark, United Kingdom and Switzerland. O. Schmitz's co-authors include Niels Møller, Oluf Pedersen, Sten Lund, Geoffrey D. Holman, K. G. M. M. Alberti, Jens Sandahl Christiansen, A. Mengel, Jens Otto Lunde Jørgensen, Bo Åhrén and Hans Ørskov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

O. Schmitz

112 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

2009 688 citations O. Schmitz et al. Diabetologia profile →

Peers

Countries citing papers authored by O. Schmitz

Since Specialization

Citations

This map shows the geographic impact of O. Schmitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Schmitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Schmitz more than expected).

Fields of papers citing papers by O. Schmitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Schmitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Schmitz. The network helps show where O. Schmitz may publish in the future.

Co-authorship network of co-authors of O. Schmitz

This figure shows the co-authorship network connecting the top 25 collaborators of O. Schmitz. A scholar is included among the top collaborators of O. Schmitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Schmitz. O. Schmitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lack of effects of high dose colecalciferol (D3) on insulin sensitivity and metabolic markers in type 2 diabetic patients: a double-blind, randomised, placebo-controlled trial 2012 ·15th International & 14th European Congress of Endocrinology ·Ulla Kampmann, Leif Mosekilde, O. Schmitz, Niels Møller, Birgitte Mønster Christensen, Louise Wamberg, L. Ørskov	1
2	Similarity of pharmacodynamic effects of a single injection of insulin glargine, insulin detemir and NPH insulin on glucose metabolism assessed by 24‐h euglycaemic clamp studies in healthy humans 2010 ·Diabetic Medicine ·Lars Peter Sørensen, Birgitte Brock, A. Mengel, Jørgen Rungby, Niels Møller, Søren Nielsen, Aage Vølund, O. Schmitz	11
3	Variation in the peroxisome proliferator-activated receptor δ gene in relation to common metabolic traits in 7,495 middle-aged white people 2007 ·Diabetologia ·Niels Grarup, Anders Albrechtsen, Jakob Ek, K. Borch‐Johnsen, Torben Jørgensen, O. Schmitz, Torben Hansen, Oluf Pedersen	36
4	Pioglitazone reduces insulin requirements and improves glycaemic control in insulin-treated patients with type 2 diabetes: results from PROactive 2006 ·Open Repository and Bibliography (University of Liège) ·O. Schmitz, B Charbonnel, André Scheen	5
5	Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP‐sensitive potassium channels, on walking distance in patients with intermittent claudication 2006 ·Diabetic Medicine ·Ulrik Markus Mortensen, Jens Erik Nielsen‐Kudsk, Hanne Maare Søndergaard, (unknown), (unknown), O. Schmitz, Thomas Nielsen	2
6	Plasma concentrations of osteoprotegerin during normo‐ and hyperglycaemic clamping 2006 ·Scandinavian Journal of Clinical and Laboratory Investigation ·S. T. Knudsen, Peter Jeppesen, (unknown), N.H. Andersen, Toke Bek, O. Schmitz, C. E. Mogensen, Lars Melholt Rasmussen	16
7	Influence of the PPAR-γ2 Pro12Ala and ACE I/D Polymorphisms on Insulin Sensitivity and Training Effects in Healthy Offspring of Type 2 Diabetic Subjects 2005 ·Hormone and Metabolic Research ·Torben Østergård, Jakob Ek, (unknown), Bengt Saltin, Oluf Pedersen, Thomas K. Hansen, O. Schmitz	31
8	Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans 2004 ·American Journal of Physiology-Endocrinology and Metabolism ·Christian Djurhuus, Claus Højbjerg Gravholt, Søren Nielsen, Steen B. Pedersen, Niels Møller, O. Schmitz	104
9	Increased adiposity and reduced adipose tissue mRNA expression of uncoupling protein‐2 in first‐degree relatives of type 2 diabetic patients: evidence for insulin stimulation of UCP‐2 and UCP‐3 gene expression in adipose tissue 2004 ·Diabetes Obesity and Metabolism ·Steen B. Pedersen, B. Nyholm, Kurt Kristensen, Michael Festersen Nielsen, O. Schmitz, Bjørn Richelsen	14
10	Effects of oral glucose on systemic glucose metabolism during hyperinsulinemic hypoglycemia in normal man 2000 ·Metabolism ·Per Løgstrup Poulsen, L. Ørskov, Thorbjørn Grøfte, J. Møller, Jens J. Holst, O. Schmitz, Niels Møller	3
11	Evidence against protein kinase B as a mediator of contraction‐induced glucose transport and GLUT4 translocation in rat skeletal muscle 1998 ·FEBS Letters ·Sten Lund, Paul R. Pryor, Søren Dinesen Østergaard, O. Schmitz, Oluf Pedersen, Geoffrey D. Holman	55
12	Plasma Amylin Immunoreactivity and Insulin Resistance in Insulin Resistant Relatives of Patients with Non-Insulin-Dependent Diabetes Mellitus 1998 ·Hormone and Metabolic Research ·B. Nyholm, Mark Fineman, (unknown), O. Schmitz	16
13	Effects of hyperinsulinaemia and hypoglycaemia on circulating leptin levels in healthy lean males. 1997 ·PubMed ·O. Schmitz, (unknown), L. Ørskov, (unknown), B. Nyholm, Niels Møller	24
14	Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus 1996 ·Metabolism ·L. Ørskov, Niels Møller, J. F. Bak, Niels Pörksen, O. Schmitz	20
15	Glut 4 content in the plasma membrane of rat skeletal muscle: comparative studies of the subcellular fractionation method and the exofacial photolabelling technique using ATB‐BMPA 1993 ·FEBS Letters ·Sten Lund, Geoffrey D. Holman, O. Schmitz, Oluf Pedersen	76
16	Assessment of Glucose Turnover Rates in Euglycaemic Clamp Studies using Primed‐constant [3‐³H]‐glucose Infusion and Labelled or Unlabelled Glucose Infusates 1992 ·Diabetic Medicine ·Ole Hother‐Nielsen, (unknown), Jan Kloppenborg Møller, Ole Rasmussen, O. Schmitz, Henning Beck‐Nielsen	52
17	Short-Term Effects of Growth Hormone on Fuel Oxidation and Regional Substrate Metabolism in Normal Man 1990 ·The Journal of Clinical Endocrinology & Metabolism ·Niels Møller, Jens Otto Lunde Jørgensen, K. G. M. M. Alberti, Allan Flyvbjerg, O. Schmitz	137
18	Marked Impairment of the Effect of Hyperglycaemia on Glucose Uptake and Glucose Production in Insulin‐dependent Diabetes 1988 ·Diabetic Medicine ·(unknown), O. Schmitz, Ole Hother‐Nielsen, (unknown), Henning Beck‐Nielsen, Kjeld Hermansen, Jens Sandahl Christiansen, K. G. M. M. Alberti, (unknown)	13
19	Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion 1988 ·Metabolism ·Kjeld Hermansen, O. Schmitz, (unknown), Cramer Christensen, J. S. Christiansen, K. G. M. M. Alberti, Hans Ørskov, C. E. Mogensen	4
20	Metabolic control in newly kidney transplanted insulin-dependent diabetics: Improvement by insulin pump treatment (CSII) 1987 ·Journal of Diabetic Complications ·O. Schmitz, Søren Schwartz Sørensen, (unknown), Hans Ørskov, Hans Erik Hansen	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact